GENPHARMASEC LIMITED Share Price

₹ 1.04

+₹0.02 (1.96%)
1D
Last updated 03 Nov, 2026, 13:10 IST
BSE: 531592
|
Dyes & Pigments

GENPHARMASEC LIMITED Share Price Today

As of 3 Nov 2026, GENPHARMASEC LIMITED share price is ₹1.04. The stock opened at ₹1.09, compared to its previous close of ₹1.02. During today's trading session, GENPHARMASEC LIMITED share price moved in the range of ₹1.02 to ₹1.09, with an average price of ₹1.06 for the day. Looking at its last 52-week, the stock has touched a low of ₹0.75 and a high of ₹1.79.

Share price over the last 1 day fell from 1.05 to 1.04, ranging between 1.02 and 1.09.
₹1.02
1.96% up today
₹1.09
1D LOW
1D HIGH

GENPHARMASEC LIMITED Stock Insights

Latest Earning
Op Profit TrendDown by 85.95% QoQ
Latest Earning
Net Profit TrendDown by 112.59% QoQ
Latest Earning
Revenue TrendUp by 289.07% YoY
Stock Performance
OutperformingBeat Nifty by 0.65 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 6.93%
GENPHARMASEC LIMITED stock performance
Open₹1.09
High₹1.09
Low₹1.02
Prev. close₹1.02
GENPHARMASEC LIMITED trading activity
Volume5,35,696
Average traded price₹1.04
Last traded time01:10:30 03 Nov
Last traded quantity120
Circuit
L
H
₹0.82
₹1.22
52-week
L
H
₹0.75
₹1.79
Mkt Cap Cr
54.82
P/E
-102.0
P/B
0.85
ROA
-0.6%
ROE
2.42%
ROCE
2.18%
Quick Ratio
1.42
EV/EBITDA
19.58

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Genpharmasec has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Genpharmasec appears overvalued compared to its peers
Earnings: 2 out of 5, Poor
Earnings
Poor
Genpharmasec earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Adani Enterprises3,48,914.3065.63.561.66%3.66%5.85%0.7218.98
PREMIER ENERGIES LIMITED40,333.5923.499.1315.43%35.05%26.37%1.215.07
Aegis Logistics38,520.5024.815.799.92%20.01%19.34%1.6716.09
Redington25,544.4816.972.514.45%14.67%15.8%1.0610.64
HONASA CONSUMER LIMITED14,411.9059.0510.4311.91%14.16%17.48%1.437.94
SG MART LIMITED10,789.4571.086.337.33%8.91%13.42%2.3440.28
LLOYDS ENTERPRISES LTD9,327.2133.042.223.28%6.84%10.45%2.4325.21
AUGMONT ENTERPRISES LTD9,081.610.00.035.03%53.18%70.24%2.710.0
MMTC7,833.0017.523.6916.0%4.72%7.79%3.47.97
GNG ELECTRONICS LIMITED7,515.6452.779.9211.36%17.42%15.97%0.935.95

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GENPHARMASEC LIMITED Company Background

ISIN
INE861N01036
Sector Market Cap
₹ 54.82 Cr

Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.

GENPHARMASEC LIMITED Financial Highlights

  • Revenue: GENPHARMASEC LIMITED reported revenue of ₹143.10 crore in FY26 vs ₹36.78 crore in FY25. It showed an increase of 289.07% on a yearly basis.
  • Operating Profit: GENPHARMASEC LIMITED reported an operating profit of ₹0.97 crore in FY26 vs ₹2.21 crore in FY25. It showed a decrease of 56.11% on a year-on-year basis.
  • Net Profit: GENPHARMASEC LIMITED reported a net profit of ₹0.56 crore in FY26 vs ₹1.56 crore in FY25. It showed a decrease of 64.10% on a yearly basis.

GENPHARMASEC LIMITED Quarterly Result Highlights

  • GENPHARMASEC LIMITED reported revenue of ₹50.08 crore in Jun 2026, compared with ₹56.45 crore in Mar 2026, representing a decrease of 11.28% on a quarter-on-quarter (QoQ) basis.
  • GENPHARMASEC LIMITED reported an operating profit of ₹0.26 crore in Jun 2026, compared with ₹1.85 crore in Mar 2026, representing a decrease of 85.95% on a quarter-on-quarter (QoQ) basis.
  • GENPHARMASEC LIMITED reported a loss of ₹0.17 crore in Jun 2026, compared with ₹1.35 crore in Mar 2026, reflecting a decrease of 112.59% on a QoQ basis.
  • The earnings per share (EPS) of GENPHARMASEC LIMITED stood at ₹0.01 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
32.06%
FII
0.00%
Other DII
0.00%
Retail and other
67.94%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

GENPHARMASEC LIMITED Investment Returns

1 day
+3.03%
1 week
+3.03%
1 month
-4.67%
1 year
-36.65%
3 years
-73.58%
5 years
-85.41%

GENPHARMASEC LIMITED Share Price History

GENPHARMASEC LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1.00 / ₹1.02
+3.03%
30 Oct 26
₹0.97 / ₹0.99
0.00%
29 Oct 26
₹0.97 / ₹0.99
+2.06%
28 Oct 26
₹1.00 / ₹0.97
-2.02%
Show more

GENPHARMASEC LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹139.94₹33.72₹30.41₹25.52
Other Income₹3.16₹3.06₹0.66₹0.10
Total Revenue₹143.09₹36.78₹31.06₹25.62
Total Expenses₹142.12₹34.57₹30.81₹25.33
Profit Before Tax₹0.97₹2.21₹0.25₹0.28
Tax₹0.41₹0.65₹0.42-₹0.84
Profit After Tax₹0.56₹1.56-₹0.17₹1.12
EPS - Basic₹0.01₹0.03-₹0.01₹0.04
EPS - Diluted₹0.01₹0.03-₹0.01₹0.04

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.97₹2.21₹0.25₹0.28
Income before WC changes₹2.93₹0.98₹0.64₹0.45
Change in Assets-₹42.82-₹4.00-₹4.78₹1.05
Change in Liabilities₹23.32₹6.05₹1.24-₹4.82
Change in WC-₹19.49₹2.05-₹3.54-₹3.77
Cash flow from Operations-₹17.55₹2.95-₹2.95-₹3.06
Cash flow from Investing₹13.26-₹4.22-₹28.06₹0.36
Cash flow from Financing₹3.92-₹1.25₹47.85₹3.08
Total Cash Flow-₹0.37-₹2.52₹16.84₹0.39
Cash (Start of the year)₹1.34₹3.17₹1.99₹1.61
Cash (End of the year)₹0.97₹0.65₹18.83₹1.99

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹57.63₹53.47₹30.15₹0.95
Current Assets₹80.52₹26.42₹40.97₹18.93
Total Assets₹138.15₹79.89₹71.13₹19.88
Current Liabilities₹47.03₹9.84₹2.70₹2.06
Net Current Asset₹33.50₹16.59₹38.27₹16.87
Non-Current Liabilities₹25.48₹4.78₹3.89₹2.48
Equity Capital₹65.64₹65.28₹64.53₹15.33
Total Equity & Liabilities₹138.15₹79.89₹71.13₹19.88

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹131.35₹32.96₹30.41₹25.52
Other Income₹4.87₹3.43₹0.72₹0.10
Total Revenue₹136.22₹36.39₹31.12₹25.62
Total Expenses₹129.78₹32.61₹30.66₹25.33
Profit Before Tax₹6.44₹3.78₹0.47₹0.28
Tax₹0.99₹0.98₹0.42-₹0.84
Profit After Tax₹5.45₹2.80₹0.05₹1.12
EPS - Basic₹0.10₹0.05₹0.00₹0.04
EPS - Diluted₹0.10₹0.05₹0.00₹0.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6.44₹3.78₹0.47₹0.28
Income before WC changes₹4.00₹0.49₹0.76₹0.45
Change in Assets-₹25.48-₹5.31-₹4.23₹1.05
Change in Liabilities₹24.22₹5.82₹1.23-₹4.82
Change in WC-₹1.25₹0.51-₹2.99-₹3.77
Cash flow from Operations₹1.93₹0.96-₹2.27-₹3.06
Cash flow from Investing-₹1.64-₹2.92-₹29.03₹0.36
Cash flow from Financing-₹0.02-₹0.44₹47.89₹3.08
Total Cash Flow₹0.27-₹2.39₹16.59₹0.39
Cash (Start of the year)₹0.52₹2.92₹1.99₹1.61
Cash (End of the year)₹0.79₹0.52₹18.58₹1.99

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹48.29₹52.16₹30.44₹0.95
Current Assets₹61.77₹26.94₹40.04₹18.93
Total Assets₹110.06₹79.09₹70.47₹19.88
Current Liabilities₹33.80₹9.26₹2.70₹2.06
Net Current Asset₹27.97₹17.68₹37.34₹16.87
Non-Current Liabilities₹4.77₹3.29₹3.21₹2.48
Equity Capital₹71.50₹66.55₹64.57₹15.33
Total Equity & Liabilities₹110.06₹79.09₹70.47₹19.88
* All values are in INR Crore
GENPHARMASEC LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
72421.041.0610694
1204671.031.0718251
32741.021.0899873
2001.011.0942700
1077411.123266
Total bid quantity1,41,957
Total ask quantity1,94,784
GENPHARMASEC LIMITED technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
47.54
Neutral
ATR (14)
0.05
Neutral
STOCH(9,6)
88.89
Bearish
STOCH RSI (14)
89.8
Bearish
ADX(9)
22.19
Bearish
UO(9)
50.07
Neutral
ROC(12)
0
Neutral
WillR(14)
-60
Neutral
Period
Simple value
Exponential vaue
5D
0.99
1
10D
1
1
20D
1.02
1.02
50D
1.08
1.06
100D
1.07
1.08
Volume trend — traded volume by day
3 Nov5L
2 Nov3L
30 Oct2L
29 Oct1L
28 Oct2L
27 Oct1L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

GENPHARMASEC LIMITED
Dyes & Pigments
Add Stock
Add Another

GENPHARMASEC LIMITED Returns Calculator

Top Gainers

AEGISLOG Share Price
₹1243.00
+142.9 (+12.99%)
KRBL Share Price
₹398.50
+35.5 (+9.78%)
BALRAMCHIN Share Price
₹654.65
+54.75 (+9.13%)
MARICO Share Price
₹862.20
+63.65 (+7.97%)
LODHA Share Price
₹1068.00
+65.2 (+6.5%)
See more

Top Losers

KEC Share Price
₹314.00
-35 (-10.03%)
GNFC Share Price
₹472.00
-39 (-7.63%)
PRAJIND Share Price
₹258.35
-12.78 (-4.71%)
GESHIP Share Price
₹1533.60
-66.8 (-4.17%)
NATIONALUM Share Price
₹316.95
-11.05 (-3.37%)
See more

GENPHARMASEC LIMITED Share Price FAQs

Please be aware that GENPHARMASEC LIMITED stock prices are subject to continuous fluctuations due to various factors.